[ad_1]
On October 26, 2020, the innovative event of MGI’s R&D and smart manufacturing base project was held in Wuhan Optics Valley. The project is located in Shendun 2nd Road, Donghu New Technology Development Zone, Wuhan. The investment in infrastructure is 1.26 billion yuan, and the total investment is expected to reach 2.4 billion yuan. The total planned construction area of the project is 86,000 square meters, and the first phase is expected to be completed and put into operation in 2022.
MGI R&D and Smart Manufacturing Core Project Start Site
Wang Zhonglin, Member of the Standing Committee of the Hubei Provincial Party Committee and Secretary of the Wuhan Municipal Party Committee, Zhou Xianwang, Deputy Secretary of the Wuhan Municipal Party Committee and Mayor of the Municipal People’s Government, and Wang Xiangwang, Member of the Standing Committee from the Wuhan Municipal Party Committee and Secretary of the Donghu High-Tech Zone Party Working Committee attended the event.Wang Jian, Co-Founder and Chairman of BGI Group, Liu Siqi, Co-Founder and Chairman of Supervisors of BGI Group, Chairman of the International Working Committee of the China Foundation for Green Development and Biodiversity Conservation, Senior Advisor to the Secretariat The United Nations, Chairman of the International Independent Advisory Panel of the Du Huixian Conference and Mu Feng, Executive Director of MGI, attended the event.
Speech by Wang Jian, Co-Founder and Chairman of Huada Group
At the opening ceremony, Wang Zhonglin, a member of the Standing Committee of the Hubei Provincial Party Committee and Secretary of the Wuhan Municipal Party Committee, announced the start of the project. Zhou Xianwang, Deputy Secretary of the Wuhan Municipal Party Committee and Mayor, and Wang Xiangwang, a member of the Standing Committee of the Wuhan Municipal Party Committee and Secretary of the Donghu Zone Work Committee, respectively, delivered high-tech speeches.
Wang Jian, co-founder and chairman of Huada Group, expressed his gratitude to the Wuhan municipal government for their strong support and presented the overall status of the project. He emphasized that Wuhan is a heroic city and has always had an indissoluble bond with BGI, and BGI is also the first group of institutions to establish branches in the Wuhan Optics Valley.
Wang Jian said: “BGI’s” Fire Eye “laboratory, which offers strong scientific guarantees for the prevention and control of the new corona epidemic, was born in Wuhan Optics Valley. The laboratory’s nucleic acid detection performance capacity has increased from 10,000 copies at the beginning to 3 times later. The number of copies per 10,000 people has been increased to 100,000 copies, and now the maximum can reach 1 million copies per day. Since millions of new copies can be made crown tests, millions of tumors and birth defects can be detected. On the one hand, the epidemic has brought unprecedented challenges have also provided opportunities. “
MGI is reported to have been established in 2016 and is based in Shenzhen, Guangdong. It has more than 1,600 employees, of which R&D staff accounts for more than 32%, and its business covers 50 countries and regions. They are the world’s top three independent research and development and mass production Qualcomm clinical. One of the companies that mass produced gene sequencers. Currently, MGI has 8 branches in Wuhan, Qingdao, Changchun, Hong Kong, the United States, Latvia, Japan, and the United Arab Emirates.
Display model of some products manufactured by MGI
Representation of MGI’s R&D and smart manufacturing base
It is worth mentioning that Wuhan is currently a major domestic MGI production base. With the start and construction of MGI’s R&D and smart manufacturing base, MGI will continue to increase a high proportion of R&D investment. Gu built a series of projects, including but not limited to: smart production base gene sequencer, gene sequencer support chip and reagent production base, and a high-end smart equipment research center. These projects will also continue to consolidate Wuhan as a major MGI production AND the status of R&D base.
Mu Feng, Executive Director of MGI, said: “The life sciences and medical and health industries have always been highly valued by the Wuhan municipal government. Based on this project, we hope to establish a quality system of world-class production in Wuhan, improve production and delivery capabilities, and combine with MGI With the advantages of R&D in Shenzhen, Qingdao, Changchun and Silicon Valley in the United States, we will continue to innovate and use independent and controllable core tools of domestic manufacturing to drive the development of life sciences from scientific research to industry and people’s livelihood, accelerating the realization of “innovation, smart manufacturing and leading life technology” ‘Vision. “Red Lei Feng Red Lei Feng Red Lei Feng(Public account: Leifeng.com)
Reproduction of original Leifeng.com articles without authorization is not permitted. See reprint instructions for details.
